We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$10.9B
AUM Growth
+$4.61B
Cap. Flow
+$4.39B
Cap. Flow %
40.45%
Top 10 Hldgs %
64.91%
Holding
930
New
269
Increased
166
Reduced
249
Closed
242

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 55.3%
2 Healthcare 12.47%
3 Technology 11.12%
4 Communication Services 7.76%
5 Financials 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JILL icon
451
J. Jill
JILL
$299M
$276K ﹤0.01%
+28,262
New +$149K
TEAM icon
452
Atlassian
TEAM
$43.4B
$274K ﹤0.01%
1,301
-2,021
-61% -$470K
FVRR icon
453
Fiverr
FVRR
$337M
$273K ﹤0.01%
+1,255
New +$308K
LOW icon
454
Lowe's Companies
LOW
$122B
$272K ﹤0.01%
1,430
+422
+42% +$72.4K
SGRY icon
455
Surgery Partners
SGRY
$1.83B
$271K ﹤0.01%
+6,118
New +$227K
QRVO icon
456
Qorvo
QRVO
$8.41B
$266K ﹤0.01%
1,455
-3,960
-73% -$695K
SWAV
457
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$266K ﹤0.01%
2,043
-3,196
-61% -$383K
PPLI
458
People Inc
PPLI
$2.89B
$265K ﹤0.01%
+2,248
New +$279K
EVTC icon
459
Evertec
EVTC
$1.77B
$263K ﹤0.01%
7,074
-87
-1% -$3.27K
EGRX
460
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$263K ﹤0.01%
+6,301
New +$293K
IRBT
461
DELISTED
iRobot
IRBT
$260K ﹤0.01%
2,130
-4,045
-66% -$460K
BHC icon
462
Bausch Health
BHC
$2.5B
$257K ﹤0.01%
8,105
-2,495
-24% -$73.2K
AMBA icon
463
Ambarella
AMBA
$3.07B
$255K ﹤0.01%
+2,542
New +$277K
PKG icon
464
Packaging Corp of America
PKG
$22.2B
$253K ﹤0.01%
1,883
-2,974
-61% -$405K
VRM icon
465
Vroom Inc
VRM
$51.1M
$247K ﹤0.01%
+79
New +$256K
CERN
466
DELISTED
Cerner Corp
CERN
$246K ﹤0.01%
3,416
+2,991
+704% +$225K
JWN
467
DELISTED
Nordstrom
JWN
$245K ﹤0.01%
6,468
-165,367
-96% -$6.11M
CATM
468
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$241K ﹤0.01%
+6,222
New +$242K
YUMC icon
469
Yum China
YUMC
$16.7B
$240K ﹤0.01%
4,045
-11,148
-73% -$666K
ETSY icon
470
Etsy
ETSY
$7.99B
$239K ﹤0.01%
1,184
-24,246
-95% -$5.07M
MLKN icon
471
MillerKnoll
MLKN
$1.58B
$236K ﹤0.01%
+5,745
New +$220K
GLUU
472
DELISTED
Glu Mobile Inc.
GLUU
$236K ﹤0.01%
18,892
+5,382
+40% +$60K
VST icon
473
Vistra
VST
$45.5B
$231K ﹤0.01%
+13,086
New +$260K
CCOI icon
474
Cogent Communications
CCOI
$486M
$230K ﹤0.01%
3,350
+2,934
+705% +$179K
OMCL icon
475
Omnicell
OMCL
$1.58B
$227K ﹤0.01%
+1,750
New +$224K

Similar funds

Lee Ainslie's Q1 2021 Portfolio in Review

As of Q1 2021, Lee Ainslie held 930 positions worth $10.9B, up 74% from $6.25B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Lee Ainslie deployed $4.39B of net new capital in Q1 2021, opening 269 new positions and adding to 166 existing holdings. Its largest new stake was Coupang: 110,527,590 shares worth $5.03B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $314M trimmed.

  • Lee Ainslie's largest Q1 2021 buy was Coupang: 110,527,590 shares worth $5.03B.
  • Lee Ainslie added most to Amazon in Q1 2021, an estimated $116M increase.
  • Lee Ainslie's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $314M.
  • Lee Ainslie fully exited Perspecta Inc. Common Stock in Q1 2021, selling an estimated $110M.
  • Lee Ainslie's ten largest holdings make up 65% of its $10.9B portfolio in Q1 2021.
  • Lee Ainslie opened 269 new positions and closed 242 in Q1 2021.
  • Lee Ainslie's portfolio value rose 74% quarter-over-quarter to $10.9B.

Based on Maverick Capital's 13F filing for Q1 2021, filed 17 May 2021.